Establishment Labs Holdings Inc

Establishment Labs Holdings Inc(ESTA)股票分析

$63.520

+1.264 (+1.99%)收盘时

Loading chart…
最高
65.610
开盘
62.070
成交量加权均价
63.70
成交量
762.56K
市值
1.21B
最低
61.980
成交额
48.58M
企业价值/息税折旧摊销前利润(TTM)
-185.20

Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.

AI 分析 of Establishment Labs Holdings Inc (ESTA)

持有

Establishment Labs Holdings Inc is currently a hold. The stock is trading at $59.18, with a forward P/E ratio of 204.08, indicating high valuation concerns. Despite a strong gross margin of 70.64% in Q2 2026 and a positive analyst price target of $117, the stock has seen a 14.60% decline over the past 20 days and significant insider selling, which raises caution. The main risk is the negative earnings trend, with EPS reported at -0.39 for Q2 2026, suggesting ongoing profitability challenges.

分析师评级(3)

上行空间 +30.48%
买入
3 买入
0 持有
0 卖出
当前: 63.52
最低
75.00
平均
82.88
最高
90.00

Citi

2026-08-13

目标价

$92

买入

Canaccord

2026-08-07

目标价

$105

买入

Mizuho

2026-07-15

目标价

$105

跑赢大盘

Citi

2026-07-08

目标价

$92

中性

BTIG

2026-05-07

目标价

$90

买入

估值指标

Establishment Labs Holdings Inc(ESTA)当前预期市盈率为 204.08,5 年平均预期市盈率为 -19.64。

预期市盈率

严重高估
5 年均值 P/E
-19.64
当前P/E
204.08
高估
24.17
低估
-63.44

预期 EV/EBITDA

合理
5 年均值 EV/EBITDA
-83.72
当前EV/EBITDA
-185.20
高估
41.95
低估
-209.40

预期市销率

合理
5 年均值 P/S
6.99
当前P/S
5.37
高估
8.79
低估
5.20

Alphio AI 对 ESTA 的价格情景

情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

乐

乐观

乐观 · 25%ESTA

$56.20

情景价格

基

基准

基准 · 50%ESTA

$47.64

情景价格

悲

悲观

悲观 · 25%ESTA

$46.67

情景价格

持有 ESTA 的大户

R

Rice Hall James & Associates, LLC

+ 持有ESTA

+1.11%

3个月收益率

S

Summit Partners Public Asset Management, LLC

+ 持有ESTA

-3.60%

3个月收益率

R

RTW Investments, LP

+ 持有ESTA

-7.17%

3个月收益率

B

Boothbay Fund Management, LLC

+ 持有ESTA

-8.82%

3个月收益率

A

ADAR1 Capital Management, LLC

+ 持有ESTA

-11.93%

3个月收益率

事件时间线

2026-09-21 (ET)

08:31:00

Establishment Labs Presents New Data on Breast Tissue Preservation

2026-06-29 (ET)

08:30:00

Establishment Labs Appoints Taylor Harris to Board of Directors

2026-05-06 (ET)

08:10:00

Company Expects Minimally Invasive Business to Exceed $35M in 2026

08:10:00

Company Reports Q1 Revenue of $59.9M, Exceeding Expectations

2026-04-30 (ET)

09:00:00

Establishment Labs Secures $300M Loan Facility

资讯

ESTA 常见问题 —— 由 Alphio AI 解答

Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).

Establishment Labs Holdings Inc is currently a hold. The stock is trading at $59.18, with a forward P/E ratio of 204.08, indicating high valuation concerns. Despite a strong gross margin of 70.64% in Q2 2026 and a positive analyst price target of $117, the stock has seen a 14.60% decline over the past 20 days and significant insider selling, which raises caution. The main risk is the negative earnings trend, with EPS reported at -0.39 for Q2 2026, suggesting ongoing profitability challenges.

3 analysts cover ESTA: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 82.88.

暂无帖子

注册或登录后参与讨论

本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。

开始交易